# Verastem, Inc.: Form D filings

Verastem, Inc., a pharmaceuticals company in Needham, MA, filed 7 Form D notices with the SEC between 2011 and 2020. The latest, on March 6, 2020, reports $100 million sold of a $100 million offering to 21 investors.

Find out what Verastem, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Verastem%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Verastem%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fverastem-inc-1526119)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Verastem%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Verastem%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fverastem-inc-1526119)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 117 KENDRICK STREET, SUITE 500, Needham, MA, 02494
- Phone: (781) 292-4200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1526119

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 6, 2020 | New notice | $100,000,000 | $100,000,000 | $0 | 21 | Feb 27, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000090445420000278/0000904454-20-000278-index.htm) |
| Jan 7, 2020 | New notice | $4,829,628 | $4,829,628 | $0 | 4 | Dec 23, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000090445420000009/0000904454-20-000009-index.htm) |
| Mar 6, 2014 | New notice | $3,898,326 | $3,898,326 | $0 | 1 | Feb 21, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000160152514000010/0001601525-14-000010-index.htm) |
| Jul 19, 2012 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | Jul 11, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000155133312000013/0001551333-12-000013-index.htm) |
| Nov 21, 2011 | Amendment | $20,402,606 | $20,402,606 | $0 | 36 | Nov 1, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000152611911000004/0001526119-11-000004-index.htm) |
| Nov 10, 2011 | New notice | $20,102,609 | $20,102,609 | $0 | 34 | Nov 1, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000152611911000003/0001526119-11-000003-index.htm) |
| Jul 26, 2011 | New notice | $32,050,000 | $32,050,000 | $0 | 23 | Jul 12, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1526119/000152611911000001/0001526119-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| BRIAN STUGLIK | Executive Officer, Director |  |
| BRUCE WENDEL | Director |  |
| ERIC ROWINSKY | Director |  |
| ALISON LAWTON | Director |  |
| TIMOTHY BARBERICH | Director |  |
| MICHAEL KAUFFMAN | Director |  |
| DAN PATERSON | Executive Officer |  |
| GINA CONSYLMAN | Director |  |
| ROB GAGNON | Executive Officer |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Mar 2, 2020](https://specstream.ai/data/form-d/week/2020-03-02) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Verastem, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).